Skip to main content
Fig. 1 | Journal of Neurodevelopmental Disorders

Fig. 1

From: Is dopamine transporter-mediated dopaminergic signaling in the retina a noninvasive biomarker for attention-deficit/ hyperactivity disorder? A study in a novel dopamine transporter variant Val559 transgenic mouse model

Fig. 1

The dark-adapted ERG is not affected by the DAT Val559 mutation in male mice. Dark-adapted a-wave (a) and b-wave (b) amplitudes (μV) plotted as a function of stimulus intensity (log cd*s/m2) in Val559 homozygous (HOM: open circles), heterozygous (HET: filled circles), and wild type (WT: filled triangles) animals. There is no significant effect of genotype on either a-wave or b-wave as revealed by two-way ANOVA (a-wave: F (2,180) = 1.146, P = 0.32; b-wave F (2,195) = 2.530, P = 0.08; n = 4–6 mice). All data are represented as means ± SEM

Back to article page

Journal of Neurodevelopmental Disorders

ISSN: 1866-1955

Contact us